Stocksigma LogoStocksigma Logo

Mangalam Drugs and Organics Schedules Board Meeting for Q2 Results Approval

Mangalam Drugs and Organics Ltd announced that a meeting of its Board of Directors is scheduled for 5th Nov'26 to consider, approve, and take on record the

Mangalam Drugs and Organics Schedules Board Meeting for Q2 Results Approval

Mangalam Drugs & Organics Ltd 路 Intimation 路 05 Nov 2026, 5:30 am

Mangalam Drugs and Organics Schedules Board Meeting for Q2 Results Approval Mangalam Drugs and Organics Ltd announced that a meeting of its Board of Directors is scheduled for 5th Nov'26 to consider, approve, and take on record the un-audited standalone and consolidated financial results for the quarter ended 30th Sep'26. Additionally, the trading window for dealing in company securities, which has been closed for designated persons since 1st Oct'26, will remain closed until 48 hours after the declaration of the financial results.

Original exchange filing (PDF)

More announcements from Mangalam Drugs & Organics Ltd

All Mangalam Drugs & Organics Ltd announcements